Old Web
English
Sign In
Acemap
>
authorDetail
>
Thomas D. Penning
Thomas D. Penning
AbbVie
Tumor initiation
Kinase
In vivo
cell killing
Programmed cell death
1
Papers
23
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (1)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A novel CDK9 inhibitor increases the efficacy of venetoclax (ABT-199) in multiple models of hematologic malignancies.
2019
Leukemia
Darren C. Phillips
Sha Jin
Gareth P. Gregory
Qi Zhang
John Xue
Xiaoxian Zhao
Jun Chen
Yunsong Tong
Haichao Zhang
Morey L. Smith
Stephen K. Tahir
Rick F. Clark
Thomas D. Penning
Jennifer R. Devlin
Jake Shortt
Eric D. Hsi
Daniel H. Albert
Marina Konopleva
Ricky W. Johnstone
Joel D. Leverson
Andrew J. Souers
Show All
Source
Cite
Save
Citations (23)
1
map